 | • レポートコード：MRC2-11QY03255 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオファーマのグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、組換えタンパク質、顆粒球コロニー刺激因子（G-CSF）、インターフェロン、組換えヒトインスリン、エリスロポエチン、ワクチン、成長ホルモン、精製タンパク質、その他）市場規模、用途別（代謝性疾患、腫瘍学、神経疾患、心血管疾患、炎症性・感染性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオファーマの競争状況、市場シェア ・世界のバイオファーマ市場：種類別市場規模 2015年-2020年（モノクローナル抗体、組換えタンパク質、顆粒球コロニー刺激因子（G-CSF）、インターフェロン、組換えヒトインスリン、エリスロポエチン、ワクチン、成長ホルモン、精製タンパク質、その他） ・世界のバイオファーマ市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、組換えタンパク質、顆粒球コロニー刺激因子（G-CSF）、インターフェロン、組換えヒトインスリン、エリスロポエチン、ワクチン、成長ホルモン、精製タンパク質、その他） ・世界のバイオファーマ市場：用途別市場規模 2015年-2020年（代謝性疾患、腫瘍学、神経疾患、心血管疾患、炎症性・感染性疾患、その他） ・世界のバイオファーマ市場：用途別市場規模予測 2021年-2026年（代謝性疾患、腫瘍学、神経疾患、心血管疾患、炎症性・感染性疾患、その他） ・北米のバイオファーマ市場分析：米国、カナダ ・ヨーロッパのバイオファーマ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオファーマ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオファーマ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオファーマ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、F. Hoffmann-La Roche AG、Johnson & Johnson Services、Sanofi, Amgen、AbbVie、Merck & Co., Inc、Biogen Idec、Bayer AG、Eli Lilly and Company、Novartis AG GlaxoSmithKline Plc、Bristol-Myers Squibb Company、AstraZeneca PLC、Abbott Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Bio-pharma Market
The global Bio-pharma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bio-pharma Scope and Market Size
Bio-pharma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio-pharma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bio-pharma market is segmented into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Segment by Application, the Bio-pharma market is segmented into
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Regional and Country-level Analysis
The Bio-pharma market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bio-pharma market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bio-pharma Market Share Analysis
Bio-pharma market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio-pharma business, the date to enter into the Bio-pharma market, Bio-pharma product introduction, recent developments, etc.
The major vendors covered:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
1 Study Coverage
1.1 Bio-pharma Product Introduction
1.2 Market Segments
1.3 Key Bio-pharma Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio-pharma Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.4.5 Interferons
1.4.6 Recombinant Human Insulin
1.4.7 Erythropoietin
1.4.8 Vaccines
1.4.9 Growth Hormones
1.4.10 Purified Proteins
1.4.11 Others
1.5 Market by Application
1.5.1 Global Bio-pharma Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Oncology
1.5.4 Neurological Disorders
1.5.5 Cardiovascular Diseases
1.5.6 Inflammatory and Infectious Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio-pharma Market Size, Estimates and Forecasts
2.1.1 Global Bio-pharma Revenue 2015-2026
2.1.2 Global Bio-pharma Sales 2015-2026
2.2 Global Bio-pharma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bio-pharma Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio-pharma Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio-pharma Competitor Landscape by Players
3.1 Bio-pharma Sales by Manufacturers
3.1.1 Bio-pharma Sales by Manufacturers (2015-2020)
3.1.2 Bio-pharma Sales Market Share by Manufacturers (2015-2020)
3.2 Bio-pharma Revenue by Manufacturers
3.2.1 Bio-pharma Revenue by Manufacturers (2015-2020)
3.2.2 Bio-pharma Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio-pharma Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio-pharma Revenue in 2019
3.2.5 Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio-pharma Price by Manufacturers
3.4 Bio-pharma Manufacturing Base Distribution, Product Types
3.4.1 Bio-pharma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio-pharma Product Type
3.4.3 Date of International Manufacturers Enter into Bio-pharma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bio-pharma Market Size by Type (2015-2020)
4.1.1 Global Bio-pharma Sales by Type (2015-2020)
4.1.2 Global Bio-pharma Revenue by Type (2015-2020)
4.1.3 Bio-pharma Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio-pharma Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio-pharma Sales Forecast by Type (2021-2026)
4.2.2 Global Bio-pharma Revenue Forecast by Type (2021-2026)
4.2.3 Bio-pharma Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio-pharma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bio-pharma Market Size by Application (2015-2020)
5.1.1 Global Bio-pharma Sales by Application (2015-2020)
5.1.2 Global Bio-pharma Revenue by Application (2015-2020)
5.1.3 Bio-pharma Price by Application (2015-2020)
5.2 Bio-pharma Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio-pharma Sales Forecast by Application (2021-2026)
5.2.2 Global Bio-pharma Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio-pharma Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio-pharma by Country
6.1.1 North America Bio-pharma Sales by Country
6.1.2 North America Bio-pharma Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio-pharma Market Facts & Figures by Type
6.3 North America Bio-pharma Market Facts & Figures by Application
7 Europe
7.1 Europe Bio-pharma by Country
7.1.1 Europe Bio-pharma Sales by Country
7.1.2 Europe Bio-pharma Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio-pharma Market Facts & Figures by Type
7.3 Europe Bio-pharma Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio-pharma by Region
8.1.1 Asia Pacific Bio-pharma Sales by Region
8.1.2 Asia Pacific Bio-pharma Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio-pharma Market Facts & Figures by Type
8.3 Asia Pacific Bio-pharma Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio-pharma by Country
9.1.1 Latin America Bio-pharma Sales by Country
9.1.2 Latin America Bio-pharma Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio-pharma Market Facts & Figures by Type
9.3 Central & South America Bio-pharma Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio-pharma by Country
10.1.1 Middle East and Africa Bio-pharma Sales by Country
10.1.2 Middle East and Africa Bio-pharma Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bio-pharma Market Facts & Figures by Type
10.3 Middle East and Africa Bio-pharma Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bio-pharma Products Offered
11.1.5 Pfizer Related Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Corporation Information
11.2.2 F. Hoffmann-La Roche AG Description and Business Overview
11.2.3 F. Hoffmann-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche AG Bio-pharma Products Offered
11.2.5 F. Hoffmann-La Roche AG Related Developments
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Corporation Information
11.3.2 Johnson & Johnson Services Description and Business Overview
11.3.3 Johnson & Johnson Services Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Services Bio-pharma Products Offered
11.3.5 Johnson & Johnson Services Related Developments
11.4 Sanofi, Amgen
11.4.1 Sanofi, Amgen Corporation Information
11.4.2 Sanofi, Amgen Description and Business Overview
11.4.3 Sanofi, Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi, Amgen Bio-pharma Products Offered
11.4.5 Sanofi, Amgen Related Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Description and Business Overview
11.5.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AbbVie Bio-pharma Products Offered
11.5.5 AbbVie Related Developments
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Corporation Information
11.6.2 Merck & Co., Inc Description and Business Overview
11.6.3 Merck & Co., Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co., Inc Bio-pharma Products Offered
11.6.5 Merck & Co., Inc Related Developments
11.7 Biogen Idec
11.7.1 Biogen Idec Corporation Information
11.7.2 Biogen Idec Description and Business Overview
11.7.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biogen Idec Bio-pharma Products Offered
11.7.5 Biogen Idec Related Developments
11.8 Bayer AG
11.8.1 Bayer AG Corporation Information
11.8.2 Bayer AG Description and Business Overview
11.8.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bayer AG Bio-pharma Products Offered
11.8.5 Bayer AG Related Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Corporation Information
11.9.2 Eli Lilly and Company Description and Business Overview
11.9.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly and Company Bio-pharma Products Offered
11.9.5 Eli Lilly and Company Related Developments
11.10 Novartis AG GlaxoSmithKline Plc
11.10.1 Novartis AG GlaxoSmithKline Plc Corporation Information
11.10.2 Novartis AG GlaxoSmithKline Plc Description and Business Overview
11.10.3 Novartis AG GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Products Offered
11.10.5 Novartis AG GlaxoSmithKline Plc Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bio-pharma Products Offered
11.1.5 Pfizer Related Developments
11.12 AstraZeneca PLC
11.12.1 AstraZeneca PLC Corporation Information
11.12.2 AstraZeneca PLC Description and Business Overview
11.12.3 AstraZeneca PLC Sales, Revenue and Gross Margin (2015-2020)
11.12.4 AstraZeneca PLC Products Offered
11.12.5 AstraZeneca PLC Related Developments
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Corporation Information
11.13.2 Abbott Laboratories Description and Business Overview
11.13.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Abbott Laboratories Products Offered
11.13.5 Abbott Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio-pharma Market Estimates and Projections by Region
12.1.1 Global Bio-pharma Sales Forecast by Regions 2021-2026
12.1.2 Global Bio-pharma Revenue Forecast by Regions 2021-2026
12.2 North America Bio-pharma Market Size Forecast (2021-2026)
12.2.1 North America: Bio-pharma Sales Forecast (2021-2026)
12.2.2 North America: Bio-pharma Revenue Forecast (2021-2026)
12.2.3 North America: Bio-pharma Market Size Forecast by Country (2021-2026)
12.3 Europe Bio-pharma Market Size Forecast (2021-2026)
12.3.1 Europe: Bio-pharma Sales Forecast (2021-2026)
12.3.2 Europe: Bio-pharma Revenue Forecast (2021-2026)
12.3.3 Europe: Bio-pharma Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio-pharma Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio-pharma Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio-pharma Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio-pharma Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio-pharma Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio-pharma Sales Forecast (2021-2026)
12.5.2 Latin America: Bio-pharma Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio-pharma Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio-pharma Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio-pharma Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio-pharma Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio-pharma Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bio-pharma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio-pharma Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bio-pharma Market Segments
Table 2. Ranking of Global Top Bio-pharma Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio-pharma Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Recombinant Proteins
Table 6. Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 7. Major Manufacturers of Interferons
Table 8. Major Manufacturers of Recombinant Human Insulin
Table 9. Major Manufacturers of Erythropoietin
Table 10. Major Manufacturers of Vaccines
Table 11. Major Manufacturers of Growth Hormones
Table 12. Major Manufacturers of Purified Proteins
Table 13. Major Manufacturers of Others
Table 14. Global Bio-pharma Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Bio-pharma Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 16. Global Bio-pharma Sales by Regions 2015-2020 (K Pcs)
Table 17. Global Bio-pharma Sales Market Share by Regions (2015-2020)
Table 18. Global Bio-pharma Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Bio-pharma Sales by Manufacturers (2015-2020) (K Pcs)
Table 20. Global Bio-pharma Sales Share by Manufacturers (2015-2020)
Table 21. Global Bio-pharma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Bio-pharma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-pharma as of 2019)
Table 23. Bio-pharma Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Bio-pharma Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Bio-pharma Price (2015-2020) (USD/Pcs)
Table 26. Bio-pharma Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Bio-pharma Product Type
Table 28. Date of International Manufacturers Enter into Bio-pharma Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 31. Global Bio-pharma Sales Share by Type (2015-2020)
Table 32. Global Bio-pharma Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Bio-pharma Revenue Share by Type (2015-2020)
Table 34. Bio-pharma Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 35. Global Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 36. Global Bio-pharma Sales Share by Application (2015-2020)
Table 37. North America Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 38. North America Bio-pharma Sales Market Share by Country (2015-2020)
Table 39. North America Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Bio-pharma Revenue Market Share by Country (2015-2020)
Table 41. North America Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 42. North America Bio-pharma Sales Market Share by Type (2015-2020)
Table 43. North America Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 44. North America Bio-pharma Sales Market Share by Application (2015-2020)
Table 45. Europe Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 46. Europe Bio-pharma Sales Market Share by Country (2015-2020)
Table 47. Europe Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Bio-pharma Revenue Market Share by Country (2015-2020)
Table 49. Europe Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 50. Europe Bio-pharma Sales Market Share by Type (2015-2020)
Table 51. Europe Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 52. Europe Bio-pharma Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Bio-pharma Sales by Region (2015-2020) (K Pcs)
Table 54. Asia Pacific Bio-pharma Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Bio-pharma Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Bio-pharma Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 58. Asia Pacific Bio-pharma Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 60. Asia Pacific Bio-pharma Sales Market Share by Application (2015-2020)
Table 61. Latin America Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 62. Latin America Bio-pharma Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Bio-pharma Revenue Market Share by Country (2015-2020)
Table 65. Latin America Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 66. Latin America Bio-pharma Sales Market Share by Type (2015-2020)
Table 67. Latin America Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 68. Latin America Bio-pharma Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Bio-pharma Sales by Country (2015-2020) (K Pcs)
Table 70. Middle East and Africa Bio-pharma Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Bio-pharma Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Bio-pharma Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Bio-pharma Sales by Type (2015-2020) (K Pcs)
Table 74. Middle East and Africa Bio-pharma Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Bio-pharma Sales by Application (2015-2020) (K Pcs)
Table 76. Middle East and Africa Bio-pharma Sales Market Share by Application (2015-2020)
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Major Businesses
Table 79. Pfizer Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. F. Hoffmann-La Roche AG Corporation Information
Table 83. F. Hoffmann-La Roche AG Description and Major Businesses
Table 84. F. Hoffmann-La Roche AG Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. F. Hoffmann-La Roche AG Product
Table 86. F. Hoffmann-La Roche AG Recent Development
Table 87. Johnson & Johnson Services Corporation Information
Table 88. Johnson & Johnson Services Description and Major Businesses
Table 89. Johnson & Johnson Services Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Johnson & Johnson Services Product
Table 91. Johnson & Johnson Services Recent Development
Table 92. Sanofi, Amgen Corporation Information
Table 93. Sanofi, Amgen Description and Major Businesses
Table 94. Sanofi, Amgen Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Sanofi, Amgen Product
Table 96. Sanofi, Amgen Recent Development
Table 97. AbbVie Corporation Information
Table 98. AbbVie Description and Major Businesses
Table 99. AbbVie Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. AbbVie Product
Table 101. AbbVie Recent Development
Table 102. Merck & Co., Inc Corporation Information
Table 103. Merck & Co., Inc Description and Major Businesses
Table 104. Merck & Co., Inc Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Merck & Co., Inc Product
Table 106. Merck & Co., Inc Recent Development
Table 107. Biogen Idec Corporation Information
Table 108. Biogen Idec Description and Major Businesses
Table 109. Biogen Idec Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Biogen Idec Product
Table 111. Biogen Idec Recent Development
Table 112. Bayer AG Corporation Information
Table 113. Bayer AG Description and Major Businesses
Table 114. Bayer AG Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Bayer AG Product
Table 116. Bayer AG Recent Development
Table 117. Eli Lilly and Company Corporation Information
Table 118. Eli Lilly and Company Description and Major Businesses
Table 119. Eli Lilly and Company Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Eli Lilly and Company Product
Table 121. Eli Lilly and Company Recent Development
Table 122. Novartis AG GlaxoSmithKline Plc Corporation Information
Table 123. Novartis AG GlaxoSmithKline Plc Description and Major Businesses
Table 124. Novartis AG GlaxoSmithKline Plc Bio-pharma Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Novartis AG GlaxoSmithKline Plc Product
Table 126. Novartis AG GlaxoSmithKline Plc Recent Development
Table 127. Bristol-Myers Squibb Company Corporation Information
Table 128. Bristol-Myers Squibb Company Description and Major Businesses
Table 129. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Bristol-Myers Squibb Company Product
Table 131. Bristol-Myers Squibb Company Recent Development
Table 132. AstraZeneca PLC Corporation Information
Table 133. AstraZeneca PLC Description and Major Businesses
Table 134. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. AstraZeneca PLC Product
Table 136. AstraZeneca PLC Recent Development
Table 137. Abbott Laboratories Corporation Information
Table 138. Abbott Laboratories Description and Major Businesses
Table 139. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Abbott Laboratories Product
Table 141. Abbott Laboratories Recent Development
Table 142. Global Bio-pharma Sales Forecast by Regions (2021-2026) (K Pcs)
Table 143. Global Bio-pharma Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global Bio-pharma Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global Bio-pharma Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. North America: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Europe: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: Bio-pharma Sales Forecast by Region (2021-2026) (K Pcs)
Table 151. Asia Pacific: Bio-pharma Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Latin America: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: Bio-pharma Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. Middle East and Africa: Bio-pharma Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Bio-pharma Players
Table 160. Bio-pharma Customers List
Table 161. Bio-pharma Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-pharma Product Picture
Figure 2. Global Bio-pharma Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Recombinant Proteins Product Picture
Figure 5. Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure 6. Interferons Product Picture
Figure 7. Recombinant Human Insulin Product Picture
Figure 8. Erythropoietin Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Growth Hormones Product Picture
Figure 11. Purified Proteins Product Picture
Figure 12. Others Product Picture
Figure 13. Global Bio-pharma Sales Market Share by Application in 2020 & 2026
Figure 14. Metabolic Disorders
Figure 15. Oncology
Figure 16. Neurological Disorders
Figure 17. Cardiovascular Diseases
Figure 18. Inflammatory and Infectious Diseases
Figure 19. Others
Figure 20. Bio-pharma Report Years Considered
Figure 21. Global Bio-pharma Market Size 2015-2026 (US$ Million)
Figure 22. Global Bio-pharma Sales 2015-2026 (K Pcs)
Figure 23. Global Bio-pharma Market Size Market Share by Region: 2020 Versus 2026
Figure 24. Global Bio-pharma Sales Market Share by Region (2015-2020)
Figure 25. Global Bio-pharma Sales Market Share by Region in 2019
Figure 26. Global Bio-pharma Revenue Market Share by Region (2015-2020)
Figure 27. Global Bio-pharma Revenue Market Share by Region in 2019
Figure 28. Global Bio-pharma Sales Share by Manufacturer in 2019
Figure 29. The Top 10 and 5 Players Market Share by Bio-pharma Revenue in 2019
Figure 30. Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Bio-pharma Sales Market Share by Type (2015-2020)
Figure 32. Global Bio-pharma Sales Market Share by Type in 2019
Figure 33. Global Bio-pharma Revenue Market Share by Type (2015-2020)
Figure 34. Global Bio-pharma Revenue Market Share by Type in 2019
Figure 35. Global Bio-pharma Market Share by Price Range (2015-2020)
Figure 36. Global Bio-pharma Sales Market Share by Application (2015-2020)
Figure 37. Global Bio-pharma Sales Market Share by Application in 2019
Figure 38. Global Bio-pharma Revenue Market Share by Application (2015-2020)
Figure 39. Global Bio-pharma Revenue Market Share by Application in 2019
Figure 40. North America Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. North America Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Bio-pharma Sales Market Share by Country in 2019
Figure 43. North America Bio-pharma Revenue Market Share by Country in 2019
Figure 44. U.S. Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. U.S. Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Canada Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. North America Bio-pharma Market Share by Type in 2019
Figure 49. North America Bio-pharma Market Share by Application in 2019
Figure 50. Europe Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Bio-pharma Sales Market Share by Country in 2019
Figure 53. Europe Bio-pharma Revenue Market Share by Country in 2019
Figure 54. Germany Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Europe Bio-pharma Market Share by Type in 2019
Figure 65. Europe Bio-pharma Market Share by Application in 2019
Figure 66. Asia Pacific Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 67. Asia Pacific Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific Bio-pharma Sales Market Share by Region in 2019
Figure 69. Asia Pacific Bio-pharma Revenue Market Share by Region in 2019
Figure 70. China Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. China Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Japan Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. South Korea Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. South Korea Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. India Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. India Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Australia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Australia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Taiwan Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Taiwan Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Indonesia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Indonesia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Thailand Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Thailand Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Malaysia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Malaysia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Philippines Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Philippines Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Vietnam Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Vietnam Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Asia Pacific Bio-pharma Market Share by Type in 2019
Figure 93. Asia Pacific Bio-pharma Market Share by Application in 2019
Figure 94. Latin America Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 95. Latin America Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Latin America Bio-pharma Sales Market Share by Country in 2019
Figure 97. Latin America Bio-pharma Revenue Market Share by Country in 2019
Figure 98. Mexico Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Mexico Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Brazil Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Brazil Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Argentina Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Argentina Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Latin America Bio-pharma Market Share by Type in 2019
Figure 105. Latin America Bio-pharma Market Share by Application in 2019
Figure 106. Middle East and Africa Bio-pharma Sales Growth Rate 2015-2020 (K Pcs)
Figure 107. Middle East and Africa Bio-pharma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 108. Middle East and Africa Bio-pharma Sales Market Share by Country in 2019
Figure 109. Middle East and Africa Bio-pharma Revenue Market Share by Country in 2019
Figure 110. Turkey Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. Turkey Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Saudi Arabia Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 113. Saudi Arabia Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. U.A.E Bio-pharma Sales Growth Rate (2015-2020) (K Pcs)
Figure 115. U.A.E Bio-pharma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 116. Middle East and Africa Bio-pharma Market Share by Type in 2019
Figure 117. Middle East and Africa Bio-pharma Market Share by Application in 2019
Figure 118. North America Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. North America Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Europe Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Asia Pacific Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 125. Latin America Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Bio-pharma Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 127. Middle East and Africa Bio-pharma Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 組換えヒトタンパク質の世界市場（～2026年） Recombinant proteins are used throughout biological and biomedical science. Their production was once the domain of experts, but the development of simple, commercially available systems has made the technology more widespread. Market Analysis and Insights: Global Recombinant Human Proteins Market T…
- 顆粒球マクロファージコロニー刺激因子の世界市場（～2026年） Market Analysis and Insights: Global Granulocyte Macrophage Colony Stimulating Factor Market The global Granulocyte Macrophage Colony Stimulating Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Granulocyte Macro…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…